Symptoms May Do Little to Improve Early Detection of Ovarian Cancer (02/05/2010)
Use of symptoms to trigger medical evaluation for ovarian cancer may not greatly increase early detection of ovarian cancer, and would result in a diagnosis of ovarian cancer in only 1 out of 100 women with symptoms. These results were published in the Journal of the National Cancer Institute.

Lapatinib Approved for Initial Treatment of Metastatic Breast Cancer (02/02/2010)
The U.S. Food and Drug Administration (FDA) has expanded its approval of Tykerb® (lapatinib) to include initial treatment of metastatic, postmenopausal breast cancer that is both HER2-positive and hormone receptor-positive. In this setting, Tykerb is approved for use in combination with the aromatase inhibitor drug Femara® (letrozole).

Don’t Forget About Your Heart Health (02/01/2010)
For better or worse, thoughts of cancer breeze into many women’s minds almost as easily as thoughts of Matthew McConaughey or breaking through the glass ceiling at work. Cancer just seems to have what it takes to grab headlines and capture the attention of movie stars and the general public alike. Heart disease, on the other hand, often has trouble just getting a mention in the news, and it sorely lags in the race for the greatest number of fundraising galas.